Host: Wayne Koff, President & CEO, Human Vaccines Project
Discussion Leaders:
• Peter Honig, MD, SVP & Head of Global Regulatory Affairs and Group Head of Development China and Development Japan, Pfizer
• Peter Marks, MD, Director, Center for Biologics Evaluation and Research, FDA
• Greg Poland, MD, Director, Mayo Clinic’s Vaccine Research Group
Discussion leaders shared their perspective on:
• Impact of regulatory policymaking to expedite development of vaccines
• Update on promising vaccines, supply chain innovations and timeline for broad distribution
• Innovative public-private collaboration to prioritize vaccine candidates, streamline clinical trial activity, and access resources across all stakeholders
Health Evolution Executive Briefings
The Race for a Vaccine: Regulatory Policymaking and Expedited Clinical Trial Innovation webcast is part of our Executive Briefings series, which are an opportunity for health care CEOs and senior leaders to connect and collaborate – both virtually and in-person to share insights and lessons learned to address critical issues facing the industry. These gatherings are designed for health care leaders to engage in discussions featuring perspectives from leading payer, provider, life science and government thought leaders, innovators and stakeholders.
To register for an upcoming webcast or watch on-demand recordings of past webcasts, visit our Executive Briefings page.
Innovation Lab
The Innovation Lab is a compilation of successful innovations focused on key CEO actions and takeaways. The Innovation Lab includes a series of Impact Reports, Innovation Guides and Innovator CEO Profiles that showcase examples of how provider, payer or life science organizations are using technology and solutions to achieve key business goals and strategic priorities.
COVID-19 Innovation Guide
Returning to the next normal of operations and care delivery will require establishing trust and ensuring safety for employees and consumers as well as leveraging digital technologies — all of which set the stage for adopting new models of care. This first in a three-part series of reports shares lessons learned by Providence, the pandemic’s original ground zero in the U.S. Read the report.
